Febuxostat is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).
Febuxostat is indicated in adults.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.